NextCure Stock Target Price and Analyst Consensus

NXTC Stock  USD 4.92  0.06  1.20%   
The current analyst and expert consensus on NextCure is Buy, with no strong buy opinions. The current projected NextCure target price consensus is 3.00 with 2 analyst opinions. Check out Macroaxis Advice on NextCure to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.
The most common way NextCure analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview NextCure executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on NextCure. We encourage you to use your own analysis of NextCure to validate this buy or sell advice. NextCure buy-or-sell recommendation module provides average expert sentiment on the projected NextCure target price to derive its highest and lowest estimates based on projected price volatility of 6.3891.
Lowest Forecast
2.73
Highest Forecast
3.33
Target Price
3
The current year's Gross Profit is expected to grow to about (3.1 M). In addition to that, Pretax Profit Margin is expected to decline to -1.55. At present, NextCure's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 14.1 M, whereas Short and Long Term Debt Total is forecasted to decline to about 4.7 M.
It's important to approach NextCure's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

NextCure Target Price Consensus

NextCure target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. NextCure's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   2  Buy
Most NextCure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand NextCure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of NextCure, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

NextCure Target Price Projection

NextCure's current and average target prices are 4.92 and 3.00, respectively. The current price of NextCure is the price at which NextCure is currently trading. On the other hand, NextCure's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

NextCure Market Quote on 24th of July 2025

Low Price4.92Odds
High Price5.23Odds

4.92

Target Price

Analyst Consensus On NextCure Target Price

Low Estimate2.73Odds
High Estimate3.33Odds

3.0

Historical Lowest Forecast  2.73 Target Price  3.0 Highest Forecast  3.33
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on NextCure and the information provided on this page.

NextCure Analyst Ratings

NextCure's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about NextCure stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of NextCure's financials, market performance, and future outlook by experienced professionals. NextCure's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize NextCure price targets

NextCure's stock target price is an estimate of its future price, usually made by analysts. Using NextCure's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at NextCure's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if NextCure's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional NextCure Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of NextCure is a key component of NextCure valuation and have some predictive power on the future returns of a NextCure.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NextCure's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.254.9211.38
Details
Intrinsic
Valuation
LowRealHigh
0.244.7411.20
Details
Naive
Forecast
LowNextHigh
0.105.2311.68
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-4.89-4.58-4.23
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Power Assets Idea
Power Assets
Invested over 90 shares
Petroleum and Natural Gas Idea
Petroleum and Natural Gas
Invested over 90 shares
Adviser Favorites Idea
Adviser Favorites
Invested over 90 shares
Dividend Beast Idea
Dividend Beast
Invested over 90 shares
Sector ETFs Idea
Sector ETFs
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
Banks Idea
Banks
Invested over 90 shares
Technology Idea
Technology
Invested few shares
Measuring and Control Equipment Idea
Measuring and Control Equipment
Invested few shares
Iron Idea
Iron
Invested over 90 shares
Corona Opportunity Idea
Corona Opportunity
Invested a lot of shares
When determining whether NextCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NextCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nextcure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nextcure Stock:
Check out Macroaxis Advice on NextCure to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Please note, the presentation of NextCure's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NextCure's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NextCure's management manipulating its earnings.